Artritis reumatoide del adulto: epidemiología, clínica y diagnóstico

de Vries, 2011, Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?, Ann Rheum Dis, 70, i51, 10.1136/ard.2010.138040 Aletaha, 2010, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Silman, 2002, Epidemiology and genetics of rheumatoid arthritis, Arthritis Res, 4, S265, 10.1186/ar578 Guillemin, 2005, Prevalence of rheumatoid arthritis in France: 2001, Ann Rheum Dis, 64, 1427, 10.1136/ard.2004.029199 van der Woude, 2018, Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis, Best Pract Res Clin Rheumatol, 32, 174, 10.1016/j.berh.2018.10.005 Alamanos, 2006, Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review, Semin Arthritis Rheum, 36, 182, 10.1016/j.semarthrit.2006.08.006 Anderson, 2000, Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration, Arthritis Rheum, 43, 22, 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9 Morel, 2006, Rheumatoid arthritis, Rev Prat, 56, 553 Morel, 2005, How to predict prognosis in early rheumatoid arthritis, Best Pract Res Clin Rheumatol, 19, 137, 10.1016/j.berh.2004.08.008 Jónsson, 1995, Clinical implications of IgA rheumatoid factor subclasses, Ann Rheum Dis, 54, 578, 10.1136/ard.54.7.578 Girbal, 1993, Characterisation of the rat oesophagus epithelium antigens defined by the so-called « antikeratin antibodies », specific for rheumatoid arthritis, Ann Rheum Dis, 52, 749, 10.1136/ard.52.10.749 Schellekens, 2000, The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide, Arthritis Rheum, 43, 155, 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3 Nishimura, 2007, Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis, Ann Intern Med, 146, 797, 10.7326/0003-4819-146-11-200706050-00008 Combe, 1995, Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage, Br J Rheumatol, 34, 529, 10.1093/rheumatology/34.6.529 Gossec, 2005, Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion, Joint Bone Spine, 72, 229, 10.1016/j.jbspin.2004.10.011 Üstergaard, 2005, Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography, Best Pract Res Clin Rheumatol, 19, 91, 10.1016/j.berh.2004.08.006 McQueen, 2003, Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis, Arthritis Rheum, 48, 1814, 10.1002/art.11162 Lard, 2001, Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies, Am J Med, 111, 446, 10.1016/S0002-9343(01)00872-5 Visser, 2005, Early diagnosis of rheumatoid arthritis, Best Pract Res Clin Rheumatol, 19, 55, 10.1016/j.berh.2004.08.005 Combe, 2007, EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, 66, 34, 10.1136/ard.2005.044354 Guillemin, 1994, Functional disability in early rheumatoid arthritis: description and risk factors, J Rheumatol, 21, 1051 Jäntti, 1999, Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study, Rheumatology (Oxford), 38, 1138, 10.1093/rheumatology/38.11.1138 Combe, 2003, Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis, J Rheumatol, 30, 2344 Smolen, 2017, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update, Ann Rheum Dis, 76, 960, 10.1136/annrheumdis-2016-210715 Felson, 2011, American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials, Arthritis Rheum, 63, 573, 10.1002/art.30129 Anderson, 2012, Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice, Arthritis Care Res (Hoboken), 64, 640, 10.1002/acr.21649 Welsing, 2004, The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis, Arthritis Rheum, 50, 2082, 10.1002/art.20350 Daien, 2019, Update of French society for rheumatology recommendations for managing rheumatoid arthritis, Joint Bone Spine, 86, 135, 10.1016/j.jbspin.2018.10.002 Sharp, 1991, The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease, Arthritis Rheum, 34, 660, 10.1002/art.1780340606 Larsen, 1987, Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year, Scand J Rheumatol, 16, 395, 10.3109/03009748709165409 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Hara, 1990, Rheumatoid pericarditis: clinical features and survival, Medicine, 69, 81, 10.1097/00005792-199069020-00002 England, 2018, Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications, BMJ, 361 Lévy, 2008, Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature, Clin Exp Rheumatol, 26, 673 Van Doornum, 2006, Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis, Arthritis Rheum, 54, 2061, 10.1002/art.21932 Agca, 2017, EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update, Ann Rheum Dis, 76, 17, 10.1136/annrheumdis-2016-209775 Juge, 2020, Recent advances in rheumatoid arthritis-associated interstitial lung disease, Curr Opin Pulm Med, 26, 477, 10.1097/MCP.0000000000000710 Bongartz, 2010, Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study, Arthritis Rheum, 62, 1583, 10.1002/art.27405 Gough, 1994, Generalised bone loss in patients with early rheumatoid arthritis, Lancet, 344, 23, 10.1016/S0140-6736(94)91049-9 Smitten, 2008, A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis, Arthritis Res Ther, 10, 10.1186/ar2404 Mariette, 2011, Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis, Ann Rheum Dis, 70, 1895, 10.1136/ard.2010.149419 Mercer, 2017, Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project, Ann Rheum Dis, 76, 2025, 10.1136/annrheumdis-2017-211623 Lazaro, 2015, Management of neutropenia in patients with rheumatoid arthritis, Joint Bone Spine, 82, 235, 10.1016/j.jbspin.2015.01.005 Murray, 2016, The eye and inflammatory rheumatic diseases: the eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Best Pract Res Clin Rheumatol, 30, 802, 10.1016/j.berh.2016.10.007 Lawry, 1984, Laryngeal involvement in rheumatoid arthritis. A clinical, laryngoscopic, and computerized tomographic study, Arthritis Rheum, 27, 873, 10.1002/art.1780270806 Helin, 1995, Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis, Arthritis Rheum, 38, 242, 10.1002/art.1780380213 Husby, 1985, Amyloidosis and rheumatoid arthritis, Clin Exp Rheumatol, 3, 173 Doran, 2002, Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study, Arthritis Rheum, 46, 2287, 10.1002/art.10524 Singh, 2015, Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis, Lancet, 386, 258, 10.1016/S0140-6736(14)61704-9 Franklin, 2007, Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis, Ann Rheum Dis, 66, 308, 10.1136/ard.2006.057265 Singh, 2011, Adverse effects of biologics: a network meta-analysis and Cochrane overview, Cochrane Database Syst Rev, 2011, CD008794 Keane, 2001, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, 345, 1098, 10.1056/NEJMoa011110 Salmon-Ceron, 2011, Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry, Ann Rheum Dis, 70, 616, 10.1136/ard.2010.137422 Humphreys, 2014, Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register, Arthritis Care Res (Hoboken), 66, 1296, 10.1002/acr.22296 Dadoun, 2013, Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis, Joint Bone Spine, 80, 29, 10.1016/j.jbspin.2012.02.005 Chiu, 2021, Lifetime risks, life expectancy, and health care expenditures for rheumatoid arthritis: a nationwide cohort followed up from 2003 to 2016, Arthritis Rheumatol, 73, 750, 10.1002/art.41597 Bukhari, 2002, Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register study, a large inception cohort, Arthritis Rheum, 46, 906, 10.1002/art.10167 Combe, 2001, Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study, Arthritis Rheum, 44, 1736, 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I